Physician profile
Thomas MD Reece
NPI 1346387636
$109,590.95
in general payments reported to CMS, 2019-2025
12 companies · $33K in 2025
The $33K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,756 · 2020: $6,563 · 2021: $19K · 2022: $9,414 · 2023: $9,322 · 2024: $23K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $6,212 · Food and Beverage: $4,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,388.75 |
| Travel and Lodging | $6,211.85 |
| Food and Beverage | $4,601.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $59,546.54 | 2019-2025 | Product In Development, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Bolton Medical INC | $41,319.52 | 2019-2025 | Thoraflex Hybrid, Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Corcym INC | $5,350.81 | 2023-2025 | Haart, Perceval, Memo 4d |
| Artivion, INC. | $1,743.65 | 2021-2025 | Jotec Products, Amds-Ascyrus Medical |
| Medtronic, INC. | $1,216.88 | 2021-2025 | Avalus, Corevalve Evolut R, Endurant Iis |
| Biostable Science & Engineering | $177.94 | 2019-2021 | |
| Baxter Healthcare | $94.10 | 2024 | Floseal |
| Abbott Laboratories | $73.00 | 2023 | Mitraclip |
| Edwards Lifesciences Corporation | $38.07 | 2023 | |
| Atricure, INC. | $30.44 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Reece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.